At the end of Q1 2025, 25 institutions reported holding Biomotion Sciences-CW29 (SLXNW) in their 13F filings, down 1 from Q4 2024. 3 opened new positions and 4 sold out. The largest holders were Polar Asset Management Partners Inc. ($57K), Linden Advisors LP ($24K) and Aristeia Capital, L.L.C. ($17K).
Company
Biomotion Sciences-CW29
Filed as
SILEXION THERAPEUTICS CORP (Q1 2025)
CUSIP
G1281K114
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
Institutions
Total Value
New Positions
3
$9K
Exits
4
$3K
All 13F filers, Q4 2024 → Q1 2025: 123,064 shares bought and 92,436 shares sold, net +30,628 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.